Viral Plaque Assay

"Viral Plaque Assay" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Method for measuring viral infectivity and multiplication in CULTURED CELLS. Clear lysed areas or plaques develop as the VIRAL PARTICLES are released from the infected cells during incubation. With some VIRUSES, the cells are killed by a cytopathic effect; with others, the infected cells are not killed but can be detected by their hemadsorptive ability. Sometimes the plaque cells contain VIRAL ANTIGENS which can be measured by IMMUNOFLUORESCENCE.

Descriptor ID	D010948
MeSH Number(s)	E01.370.225.875.970.790 E05.200.875.970.790
Concept/Terms	Viral Plaque Assay Viral Plaque Assay Assay, Viral Plaque Assays, Viral Plaque Plaque Assay, Viral Plaque Assays, Viral Viral Plaque Assays Bacteriophage Plaque Assay Bacteriophage Plaque Assay Assay, Bacteriophage Plaque Assays, Bacteriophage Plaque Bacteriophage Plaque Assays Plaque Assay, Bacteriophage Plaque Assays, Bacteriophage

Below are MeSH descriptors whose meaning is more general than "Viral Plaque Assay".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Diagnostic Techniques and Procedures [E01.370]
Clinical Laboratory Techniques [E01.370.225]
Microbiological Techniques [E01.370.225.875]
Virus Cultivation [E01.370.225.875.970]
Viral Plaque Assay [E01.370.225.875.970.790]
Investigative Techniques [E05]
Clinical Laboratory Techniques [E05.200]
Microbiological Techniques [E05.200.875]
Virus Cultivation [E05.200.875.970]
Viral Plaque Assay [E05.200.875.970.790]

Below are MeSH descriptors whose meaning is related to "Viral Plaque Assay".

Below are MeSH descriptors whose meaning is more specific than "Viral Plaque Assay".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Viral Plaque Assay" by people in this website by year, and whether "Viral Plaque Assay" was a major or minor topic of these publications.

Bar chart showing 8 publications over 7 distinct years, with a maximum of 2 publications in 2007

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2005	0	1	1
2006	0	1	1
2007	0	2	2
2008	0	1	1
2010	0	1	1
2013	0	1	1
2020	1	0	1

Below are the most recent publications written about "Viral Plaque Assay" by people in Profiles.

Duong MM, Carmody CM, Ma Q, Peters JE, Nugen SR. Optimization of T4 phage engineering via CRISPR/Cas9. Sci Rep. 2020 10 26; 10(1):18229.

View in: PubMed
Rydyznski C, Daniels KA, Karmele EP, Brooks TR, Mahl SE, Moran MT, Li C, Sutiwisesak R, Welsh RM, Waggoner SN. Generation of cellular immune memory and B-cell immunity is impaired by natural killer cells. Nat Commun. 2015 Feb 27; 6:6375.

View in: PubMed
Buddhari D, Aldstadt J, Endy TP, Srikiatkhachorn A, Thaisomboonsuk B, Klungthong C, Nisalak A, Khuntirat B, Jarman RG, Fernandez S, Thomas SJ, Scott TW, Rothman AL, Yoon IK. Dengue virus neutralizing antibody levels associated with protection from infection in thai cluster studies. PLoS Negl Trop Dis. 2014 Oct; 8(10):e3230.

View in: PubMed
Brush LA, Black DH, Mccormack KA, Maxwell LK, Wright G, Ritchey JW, Payton ME, Eberle R. Papiine herpesvirus 2 as a predictive model for drug sensitivity of Macacine herpesvirus 1 (monkey B virus). Comp Med. 2014 Oct; 64(5):386-93.

View in: PubMed
Renzette N, Caffrey DR, Zeldovich KB, Liu P, Gallagher GR, Aiello D, Porter AJ, Kurt-Jones EA, Bolon DN, Poh YP, Jensen JD, Schiffer CA, Kowalik TF, Finberg RW, Wang JP. Evolution of the influenza A virus genome during development of oseltamivir resistance in vitro. J Virol. 2014 Jan; 88(1):272-81.

View in: PubMed
van Panhuis WG, Gibbons RV, Endy TP, Rothman AL, Srikiatkhachorn A, Nisalak A, Burke DS, Cummings DA. Inferring the serotype associated with dengue virus infections on the basis of pre- and postinfection neutralizing antibody titers. J Infect Dis. 2010 Oct 01; 202(7):1002-10.

View in: PubMed
Singh R, Rothman AL, Potts J, Guirakhoo F, Ennis FA, Green S. Sequential immunization with heterologous chimeric flaviviruses induces broad-spectrum cross-reactive CD8+ T cell responses. J Infect Dis. 2010 Jul 15; 202(2):223-33.

View in: PubMed
Thomas SJ, Nisalak A, Anderson KB, Libraty DH, Kalayanarooj S, Vaughn DW, Putnak R, Gibbons RV, Jarman R, Endy TP. Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: How alterations in assay conditions impact performance. Am J Trop Med Hyg. 2009 Nov; 81(5):825-33.

View in: PubMed
Fang M, Nie Y, Dai X, Theilmann DA. Identification of AcMNPV EXON0 (ac141) domains required for efficient production of budded virus, dimerization and association with BV/ODV-C42 and FP25. Virology. 2008 May 25; 375(1):265-76.

View in: PubMed
Welsh RM, Seedhom MO. Lymphocytic choriomeningitis virus (LCMV): propagation, quantitation, and storage. Curr Protoc Microbiol. 2008 Feb; Chapter 15:Unit 15A.1.

View in: PubMed

People

Explore

Similar Concepts

Top Journals